We are live on
!
Find out more
Axa Portfolio holdings
AUM
$256M
1-Year Est. Return
25.01%
This Fund
S&P 500
This Quarter
Est. Return
+16.76%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$25.6B
AUM Growth
+$2.65B
(+12%)
Cap. Flow
-$1.17B
Cap. Flow
% of AUM
-4.57%
Top 10 Holdings %
Top 10 Hldgs %
14.38%
Holding
1,445
New
151
Increased
481
Reduced
509
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$56.6M |
| 2 |
Fidelity National Information Services
FIS
|
+$53M |
| 3 |
Advanced Micro Devices
AMD
|
+$48.1M |
| 4 |
RTX Corp
RTX
|
+$43.3M |
| 5 |
Analog Devices
ADI
|
+$38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$72.1M |
| 2 |
PepsiCo
PEP
|
+$70.8M |
| 3 |
American Express
AXP
|
+$70.7M |
| 4 |
Automatic Data Processing
ADP
|
+$49.7M |
| 5 |
Synchrony
SYF
|
+$47.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.3% |
| 2 | Healthcare | 15.12% |
| 3 | Consumer Discretionary | 10% |
| 4 | Financials | 9.68% |
| 5 | Industrials | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADVM
976
DELISTED
Adverum Biotechnologies
ADVM
| $918K | ﹤0.01% |
17,525
+620
| +4% | +$25.1K |
|
977
Dover
DOV
$26.7B
| $907K | ﹤0.01% |
9,670
-117,767
| -92% | -$10.2M |
|
978
KB Financial Group
KB
$40.6B
| $905K | ﹤0.01% |
24,421
| – | – |
|
979
iShares MSCI EAFE ETF
EFA
$76.4B
| $903K | ﹤0.01% |
13,916
-35,850
| -72% | -$2.26M |
|
980
Williams-Sonoma
WSM
$27.5B
| $900K | ﹤0.01% |
32,000
-2,800
| -8% | -$77.2K |
|
981
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.41B
| $899K | ﹤0.01% |
21,180
+540
| +3% | +$22.3K |
|
982
Sprouts Farmers Market
SFM
$7.44B
| $897K | ﹤0.01% |
41,634
+26,564
| +176% | +$623K |
|
983
Fidelity National Financial
FNF
$14.4B
| $894K | ﹤0.01% |
25,433
-274,532
| -92% | -$9.2M |
|
984
Apple Hospitality REIT
APLE
$3.97B
| $890K | ﹤0.01% |
54,614
-554,500
| -91% | -$8.89M |
|
|
XRN
985
Chiron Real Estate Inc
XRN
$535M
| $884K | ﹤0.01% |
+18,000
| New | +$887K |
|
986
iShares 20+ Year Treasury Bond ETF
TLT
$42.4B
| $879K | ﹤0.01% |
6,954
-6,377
| -48% | -$776K |
|
987
iShares Morningstar Mid-Cap ETF
IMCB
$1.65B
| $877K | ﹤0.01% |
18,664
| – | – |
|
|
EIGI
988
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $877K | ﹤0.01% |
120,971
-62,044
| -34% | -$452K |
|
989
OFG Bancorp
OFG
$2.21B
| $857K | ﹤0.01% |
43,300
| – | – |
|
990
Federated Hermes
FHI
$4.56B
| $850K | ﹤0.01% |
29,000
-16,000
| -36% | -$444K |
|
991
Vanguard S&P 500 ETF
VOO
$956B
| $849K | ﹤0.01% |
3,270
-8,485
| -72% | -$2.12M |
|
|
BELFB
992
Bel Fuse Inc Class B
BELFB
$3.45B
| $848K | ﹤0.01% |
33,528
| – | – |
|
993
Vanguard Energy ETF
VDE
$9.9B
| $847K | ﹤0.01% |
9,480
+310
| +3% | +$26.9K |
|
994
Tyson Foods
TSN
$21.5B
| $840K | ﹤0.01% |
12,100
-21,141
| -64% | -$1.31M |
|
|
PPL
995
PPL Corp
PPL
$26.9B
| $833K | ﹤0.01% |
26,248
-20,483
| -44% | -$637K |
|
|
VER
996
DELISTED
VEREIT, Inc.
VER
| $826K | ﹤0.01% |
19,738
-247,827
| -93% | -$9.9M |
|
997
Dr. Reddy's Laboratories
RDY
$9.8B
| $805K | ﹤0.01% |
99,420
| – | – |
|
|
FISV
998
Fiserv Inc
FISV
$29.7B
| $804K | ﹤0.01% |
9,097
-343,623
| -97% | -$28.4M |
|
|
REV
999
DELISTED
Revlon, Inc.
REV
| $804K | ﹤0.01% |
+41,500
| New | +$1M |
|
|
FLG
1000
Flagstar Bank National Association
FLG
$5.87B
| $802K | ﹤0.01% |
23,100
+1,633
| +8% | +$56.2K |
|
Similar funds
PHAM
HFRG
EBWM
GCCM
CIA
KAM
ACM
CCA
Axa's Q1 2019 Portfolio in Review
As of Q1 2019, Axa held 1,445 positions worth $25.6B, up 12% from $22.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Axa withdrew a net $1.17B in Q1 2019, closing 137 positions and reducing 509 holdings. Its most notable exit was Newfield Exploration, an estimated $15.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Axa opened a new position in BlackBerry worth $40.1M.
- Axa's largest Q1 2019 buy was BlackBerry: 3,971,844 shares worth $40.1M.
- Axa added most to Gilead Sciences in Q1 2019, an estimated $56.6M increase.
- Axa's biggest Q1 2019 reduction was Humana, cutting an estimated $72.1M.
- Axa fully exited Newfield Exploration in Q1 2019, selling an estimated $15.3M.
- Axa's ten largest holdings make up 14% of its $25.6B portfolio in Q1 2019.
- Axa opened 151 new positions and closed 137 in Q1 2019.
- Axa's portfolio value rose 12% quarter-over-quarter to $25.6B.
Based on Axa's 13F filing for Q1 2019, filed 14 May 2019.